ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals Inc (QB) (ELTP)

0.46175
0.00425
( 0.93% )
Updated: 15:19:50

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.46175
Bid
0.46
Ask
0.4635
Volume
301,222
0.4513 Day's Range 0.468
0.1213 52 Week Range 0.7598
Market Cap
Previous Close
0.4575
Open
0.45325
Last Trade
1500
@
0.46175
Last Trade Time
15:19:50
Financial Volume
$ 139,117
VWAP
0.461842
Average Volume (3m)
1,036,586
Shares Outstanding
1,068,273,108
Dividend Yield
-
PE Ratio
24.47
Earnings Per Share (EPS)
0.02
Revenue
56.63M
Net Profit
20.11M

About Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma... Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Carson City, Nevada, USA
Founded
-
Elite Pharmaceuticals Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker ELTP. The last closing price for Elite Pharmaceuticals (QB) was $0.46. Over the last year, Elite Pharmaceuticals (QB) shares have traded in a share price range of $ 0.1213 to $ 0.7598.

Elite Pharmaceuticals (QB) currently has 1,068,273,108 shares outstanding. The market capitalization of Elite Pharmaceuticals (QB) is $488.73 million. Elite Pharmaceuticals (QB) has a price to earnings ratio (PE ratio) of 24.47.

ELTP Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.00845-1.797107613780.47020.49230.45076007280.47001098CS
4-0.04725-9.282907662080.5090.5090.45076291870.4804069CS
12-0.09425-16.95143884890.5560.570.44510365860.50489169CS
260.0868523.16617764740.37490.75980.362119885900.53006959CS
520.31225208.8628762540.14950.75980.121315602590.42628044CS
1560.422151066.035353540.03960.75980.026810057100.26730613CS
2600.40695742.6094890510.05480.75980.0239694680.18767285CS

ELTP - Frequently Asked Questions (FAQ)

What is the current Elite Pharmaceuticals (QB) share price?
The current share price of Elite Pharmaceuticals (QB) is $ 0.46175
How many Elite Pharmaceuticals (QB) shares are in issue?
Elite Pharmaceuticals (QB) has 1,068,273,108 shares in issue
What is the market cap of Elite Pharmaceuticals (QB)?
The market capitalisation of Elite Pharmaceuticals (QB) is USD 488.73M
What is the 1 year trading range for Elite Pharmaceuticals (QB) share price?
Elite Pharmaceuticals (QB) has traded in the range of $ 0.1213 to $ 0.7598 during the past year
What is the PE ratio of Elite Pharmaceuticals (QB)?
The price to earnings ratio of Elite Pharmaceuticals (QB) is 24.47
What is the cash to sales ratio of Elite Pharmaceuticals (QB)?
The cash to sales ratio of Elite Pharmaceuticals (QB) is 8.68
What is the reporting currency for Elite Pharmaceuticals (QB)?
Elite Pharmaceuticals (QB) reports financial results in USD
What is the latest annual turnover for Elite Pharmaceuticals (QB)?
The latest annual turnover of Elite Pharmaceuticals (QB) is USD 56.63M
What is the latest annual profit for Elite Pharmaceuticals (QB)?
The latest annual profit of Elite Pharmaceuticals (QB) is USD 20.11M
What is the registered address of Elite Pharmaceuticals (QB)?
The registered address for Elite Pharmaceuticals (QB) is 321 W. WINNIE LANE, #104, CARSON CITY, NEVADA, 89703
What is the Elite Pharmaceuticals (QB) website address?
The website address for Elite Pharmaceuticals (QB) is www.elitepharma.com
Which industry sector does Elite Pharmaceuticals (QB) operate in?
Elite Pharmaceuticals (QB) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EGSEEvergreen Sustainable Enterprises Inc (CE)
$ 0.0008
(79,900.00%)
115
HLLPFHello Pal International Inc (CE)
$ 0.0005
(49,900.00%)
1,000
SBESSouth Beach Spirits Inc (CE)
$ 0.0002
(19,900.00%)
6M
BETSFBit Brother Ltd (CE)
$ 0.04
(13,233.33%)
140
NOUVNouveau Life Pharmaceuticals Inc (PK)
$ 0.0001
(9,900.00%)
7.2M
ZMMHZhongMin Meihao Holding Company Ltd (CE)
$ 0.000001
(-99.98%)
225k
STTOSITO Mobile Ltd (CE)
$ 0.0004
(-99.76%)
278
LSDIFLucy Scientific Discovery Inc (CE)
$ 0.000001
(-99.50%)
1,000
INTKIndustrial Nanotech Inc (PK)
$ 0.000001
(-99.33%)
3.03M
NVOSNovo Integrated Sciences Inc (CE)
$ 0.0005
(-99.07%)
11.21k
KGKGKona Gold Beverage Inc (PK)
$ 0.0001
(-25.93%)
530.48M
ASIIAccredited Solutions Inc (PK)
$ 0.00045
(34.33%)
510.54M
HMBLHUMBL Inc (PK)
$ 0.0003
(0.00%)
240.25M
TPTWTPT Global Tech Inc (PK)
$ 0.0002
(0.00%)
155.98M
AITXArtificial Intelligence Technology Solutions Inc (PK)
$ 0.0021
(-4.55%)
116.05M

ELTP Discussion

View Posts
jammy32 jammy32 22 minutes ago
Not a basher weez. I own the stock and have made 7 figures so I’m happy. Just think Nasrat can do more. That’s what CEO’s are supposed to do, more.
👍️ 1 🙈 2 ☠️ 2
TurboMountain96 TurboMountain96 30 minutes ago
34 percent. Invested alongside Gold and Silver miners
👍️ 1
DrSleep DrSleep 31 minutes ago
50%. This percent will increase as I add.
👍️0
rahrah rahrah 36 minutes ago
16%
👍️0
$7.00 or Nothing $7.00 or Nothing 38 minutes ago
99.7%
👍️0
Makai63 Makai63 48 minutes ago
100%
👍️ 1
TurboMountain96 TurboMountain96 57 minutes ago
Does anybody here own any other stocks or are we all just invested in ELTP? Be interesting to know how much of a portfolio ELTP takes up
👍️ 1
namtae namtae 1 hour ago
Has Mikah conducted any other pharma business besides what's known re Adderall?

Perhaps picking the bones of Lannett?

Who would know
👍️0
imanjen13 imanjen13 2 hours ago
On June 10, 2021, almost 4 years ago, a cost and profit sharing, master development, license agreement was made between Elite and Mikah. At the time the stock price was under 5 cents a share. NH put up his own money to purchase the SunGen rights to Adderall and the company has thrived since with record revenues and new ANDAs. Had he not stepped up to the plate, who knows where we would be now. He was all in years ago and deserves both the credit and the rewards for making this company a force in the generic drug field.
👍️ 5 💯 3 😵 1 🤧 1
luvwetscent luvwetscent 2 hours ago
Crook..without a doubt
👍️ 1 ✊️ 1
luvwetscent luvwetscent 2 hours ago
Ahahaha!!
👍️ 1 😝 1
WeeZuhl WeeZuhl 2 hours ago
Kool aide drinkers don't see red flags. They see otc fantasy dreams. Watch and learn. Bridges are coming.


You are by far the least creative and most boring basher in the history of the ihub ELTP board. Even Jammy changes his tune occasionally.

.
👿 1 💘 1 ☝️ 1 ❤️ 1
HenryB3 HenryB3 2 hours ago
Kool aide drinkers don't see red flags. They see otc fantasy dreams. Watch and learn. Bridges are coming.
👍️ 1 🗑️ 2 😗 1 🩳 1
WeeZuhl WeeZuhl 2 hours ago
NO ONE CARES about what happened 10 years ago!

You should. What about his 79 million warrants? What did he do to deserve those? How did awarding himself 79 million warrants benefit ELTP shareholders? To this day those warrants are dragging down our bottom line. Nothing but pure unadulterated CEO greed from years ago that will continue to kill our net income right up until it knocks down the buyout price. Fine for Hakim with 300M+ shares and a secret Mikah side deal, but as usual with this ticker, retail investors will get the shaft. It's sad to see some ELTP shareholders who ignore facts and are therefore unable to see that Hakim's interests are not aligned with the interests of other shareholders. Hakim can negotiate a stellar deal for himself, while leaving us out in the cold, and history proves he will do it, if we let him.

.
👍 2 🤕 1 🤢 1 🤧 1
$7.00 or Nothing $7.00 or Nothing 2 hours ago
Fascinating discussion between Jammy Version 32 and Henry Version B3 Amazed by bots
----------------------------

Jammy32:
I’m very concerned about the PPS and the why. Nasrat has gone silent after placing a cap on the priice by saying it’s only worth 50 cents. Where is all the great news. Where is the support of the PPS. Why is MIKAH even an issue. Nasrat is waiting to long and I hope we don’t drop to single digits again. Just my opinion

HenryB3:
Kool aide is starting to taste funny? I think its turning bitter. But OTC fantasy world has buyout at $3 or more. I think not. No buyouts happen on messageboards. Only false hopes and rumors, while others sell. Classic OTC 101. I have Red bridges for sale, instead of red flags. Who wants one?
👍️ 3 😃 3
Choozelife Choozelife 3 hours ago
Oh Henry, I never cared for your candy bar.
👎️ 1 😂 1 🤣 1 🤲 1
JamesF1 JamesF1 3 hours ago
Yes, the key is to look forward rather than backwards. No matter what you think of Nasrat’s trustworthiness, he is the largest shareholder of ELTP. He will do whatever he can to sell the company at the highest price obtainable.
👌 2 👍️ 6 😴 1
kayak_wench kayak_wench 3 hours ago
NO ONE CARES about what happened 10 years ago!

The only people here who still think or care about what happened a decade or more ago are the people who sold their shares before their investment increased by a factor of 5 to 10.

So you are wrong, I wasn't making any such attempt. I really thought you were being a snob about not wanting another companies rejects, which would have made you dumb if it had been true. But your inability to see the current potential and value in Elite and Nasrat, despite it now being a stable profitable company, and to have missed out on an amazing opportunity to profit greatly is sadder and dumber.
👍️ 6
Dr Speculator Ninja Dr Speculator Ninja 3 hours ago
Sub-12-cent bridges! 🤣 The Pipe-dream Plumber's Daily Prognostication! What a steal! Are you offering a 'buy one, get a dozen free' deal if the price hits .12 cents? Or perhaps a 'frequent bridge buyer' loyalty program? I'm picturing "Henry's Pipe-Dream Punch Cards": 'Buy 10 bridges, get a free pitcher of diluted International Kool-Aide.' - Bitter Flavor! The possibilities are endless!

Fortunately for those smart enough to buy $ELTP we won't need your fantasy bridges. In fact, my average cost is well below .16... which is where you could have bought in August of 2024! Ouch!

Tick-tock. Not much more time to try scare as many people as you can... 🫣⌛️
🎓️ 4 👍️ 3 👑 3 🤏 1 🤢 1
Dr Speculator Ninja Dr Speculator Ninja 4 hours ago
Speaking of bitter, it's a shame you didn't buy $ELTP at .16 when you had the chance. 😩 Man, you could have tripled your money - and that's just the beginning! At this rate you'll miss the .40s and .50s entry point too.

Tick-tock. Only a few more weeks left to sell international Kool-"Aide" and fantasy bridges.

I think its turning bitter.
🎓️ 4 🏆️ 2 👍️ 4 😝 1 🫸 1
imanjen13 imanjen13 4 hours ago
Thanks for the info.
👍️ 3
JamesF1 JamesF1 4 hours ago
The Elite/Nostrum deals were definitely beneficial to Elite stockholders. Nasrat did well for us there. As for Trimipramine, you may have a point.
👍️ 2
JamesF1 JamesF1 4 hours ago
ANDA’s can definitely be bought and sold. I believe the FDA has to approve a site transfer before production begins.
👍️ 2
WeeZuhl WeeZuhl 4 hours ago
The purchase/re-purchase of the opioid shares clearly shows that divestiture ANDAs can result in substantial increase in revenue for Elite and bring in that revenue in a very short time.


Nice attempt at changing the context. Clearly my post was referring to original Mikah generics and subsequent trimipramine transfer. Most of these were purchased by Mikah at "divestiture" sales when two companies merge with overlapping products. He bought them for thousands of dollars and sold them to Elite shareholders for millions of dollars in non-arm's length deals that shareholders were unable to refuse. If he wanted for Elite to own trimipramine, then why not have Elite buy the ANDA instead of Mikah? After all, we were told in at least 4 annual reports that Mikah had ceased operations. The answer is obvious, Hakim wanted to be in the middle of the transaction to turn huge personal profit at the expense of ELTP shareholders. He could have been transparent about the costs. He could have requested shareholder approval. Instead he keeps all the details top secret and forces the unfair deals on shareholders. Hakim is a miserable failure when it comes to fulfilling his fiduciary duty to Elite shareholders.

.
👍️ 1 👎️ 1 👑 1 💯 3 🚽 1
$7.00 or Nothing $7.00 or Nothing 4 hours ago
So how come Nasrat sod 5 andas in the past and bought 3 back?

And how come Nasrat 10 andas to elite when he joined the company through mikah?
👍️ 1
imanjen13 imanjen13 4 hours ago
Not sure you can buy a ANDA when you didn't get FDA approval. to manufacture it. The ANDAs they reacquired were ones Elite divested.
👍️0
NASDAQ2020 NASDAQ2020 4 hours ago
Were any of Elite's lawyers involved in the Purdue/Accord trials. ??
👍️0
kayak_wench kayak_wench 4 hours ago
The purchase/re-purchase of the opioid shares clearly shows that divestiture ANDAs can result in substantial increase in revenue for Elite and bring in that revenue in a very short time. In fact, that is an excellent example of how a company not having a need (or not wanting to use) an ANDA can result in a bargain purchase for another company.

Remember Nasrat took the initiative to ask about buying back the opioids. Probably helped get the low price because the company didn't have to do much to get some cash and get rid of ANDAs they weren't using.

Nasrat has been an amazing CEO for investors that have held their shares.
🎓️ 2 👍️ 5 💯 1
NASDAQ2020 NASDAQ2020 4 hours ago
Hammer Time !!!!!!!!!!!!!!!
💤 1
NASDAQ2020 NASDAQ2020 5 hours ago
What do they (CREDITOR) know about running a pharmaceutical ?
👍️0
$7.00 or Nothing $7.00 or Nothing 5 hours ago
Weezuhl is back
👍️ 1
WeeZuhl WeeZuhl 5 hours ago
The Mallinkrodt and Endo merger that recently was announced may create an opportunity to purchase ANDA’s. There is overlap in their portfolios.


I hear Mikah is flush with cash and ready to buy some divestiture ANDA's. ELTP shareholders lubing up for more buggering by their self-dealing CEO.

.
🌈 1 👏 1 💤 1 💯 1 🕳️ 1 🗑️ 2 😖 1 🚽 1
JamesF1 JamesF1 5 hours ago
Hi namtae, thanks for the clarification. After the reorganization IMO there is no reason to believe that Lannett is in such dire financial condition that it will sell ANDAs cheaply.
👍️0
namtae namtae 5 hours ago
Bankruptcy reorg doesnt necessarily erase debt. If successfully negotiated, it may be reorganize in multiple ways, such as exchange for equity, extension of maturity and lots of other options

Chapter 7 is what erases debt, not Chapter 11
🎓️ 1 👁️ 2 👍️ 3 🥵 2
JamesF1 JamesF1 5 hours ago
The Mallinkrodt and Endo merger that recently was announced may create an opportunity to purchase ANDA’s. There is overlap in their portfolios.
👍️ 3
JamesF1 JamesF1 6 hours ago
Yes. Bankruptcy reorganization erases debt. The former creditors now own the company. The former owners (stockholders) lost everything.
👍️ 3 💯 1
HenryB3 HenryB3 6 hours ago
Kool aide is starting to taste funny? I think its turning bitter. But OTC fantasy world has buyout at $3 or more. I think not. No buyouts happen on messageboards. Only false hopes and rumors, while others sell. Classic OTC 101. I have Red bridges for sale, instead of red flags. Who wants one?
👍️ 1 🗑️ 1 🩳 1 🫡 1
$7.00 or Nothing $7.00 or Nothing 6 hours ago
Are you saying the $600 million they owed just vanished?

If you have a drug with potential and you need money but that drug does not bring money now because you cannot get API, wouldn't you sell it?

I may be wrong - but just trying to look at opportunities. Nasrat did mention a few times ANDA's acquisitions - was he only thinking of the 3 ANDA's he bought back?
👍️0
JamesF1 JamesF1 6 hours ago
Hi HGilS, I’m inclined to agree with imanjen13. I don’t believe Lannett is in financial distress at the moment. Anything purchased from them IMHO will be expensive.
👍 3
$7.00 or Nothing $7.00 or Nothing 6 hours ago
imanjen - no feelings should be put in business decisions

If we could take Lannett Vyvanse quota, that would put us in a different league
👍️ 1
imanjen13 imanjen13 6 hours ago
F Lannett. They abrogated their distribution deal to sell our Adderall early when they got approved for their own generic. What appeared to be a disaster for Elite turned out to be a blessing in disguise as NH decided to try to sell its own drugs and hired Kirkov.
I say let sleeping dogs lie.
👍️ 5
$7.00 or Nothing $7.00 or Nothing 6 hours ago
There are other options also for Lannett - they can use Elite for contract manufacturing and reduce their internal costs by selling manufacturing facilities.
👍️0
$7.00 or Nothing $7.00 or Nothing 6 hours ago
Do not underestimate the strength of ANDA's purchase to feed our growth - no BE study etc...
🎓️ 1 👍️ 2
NASDAQ2020 NASDAQ2020 6 hours ago
Lannett has Adderall I see

Vyvance getting sketchy
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lisdexamfetamine%20Dimesylate%20Capsule&st=c
👍️0
$7.00 or Nothing $7.00 or Nothing 6 hours ago
They restructured their 600 Million debt - but they still OWE money.

Best way to deal with that is to sell some ANDA's and go small and rebuild the company like Nasrat did.
👍️ 2
jour_trader jour_trader 6 hours ago
They are privately held now, by I believe the creditors. Much stronger financial position as they converted a significant portion of their debt to equity freeing up cash flow to invest in growth. They are doing just fine with or without Lisdex. 
👍️ 1
JamesF1 JamesF1 6 hours ago
Lannett emerged from a bankruptcy reorganization June 2023. They are not selling off assets for pennies on the dollar any longer. They are a competitor to Elite for both Adderall and Vyvanse. I’d like Elite to expand their portfolio. The best way is having ANDA’s approved.
🎓️ 2 👍 3
$7.00 or Nothing $7.00 or Nothing 6 hours ago
Yes - I saw that, they do not trade anymore LCI is dead ticker. However they still function and I believe they need $...

They do sell Vyvanse - but if they do not have API, then this may be a good reason to sell.
👍️0
NASDAQ2020 NASDAQ2020 6 hours ago
They must be DEEP in debt ? Seems like that portfolio would be adequate.
👍️0
$7.00 or Nothing $7.00 or Nothing 6 hours ago
Pick your Bankrupt Lannett products:OR QUOTAS open for the grab

Capsules, Tablets
Amphetamine Sulfate Tablets
Azithromycin Tablets
Baclofen Tablets
Butalbital w/ Acetaminophen & Caffeine Capsules
Butalbital w/ Acetaminophen & Caffeine Tablets
Butalbital w/ Aspirin & Caffeine CIII Capsules
Chlorpromazine Tablets
Clarithromycin Tablets
Codeine Sulfate (CII) Tablets
Danazol Capsules
Dextroamphetamine/Amphetamine ER Capsules
Dextroamphetamine/Amphetamine IR Tablets
Dicyclomine HCl Capsules
Dicyclomine HCl Tablets
Diethylpropion HCl CIV Tablets
Doxycycline Monohydrate Tablets
Entacapone Tablets
Esomeprazole Magnesium Capsules
Febuxostat Tablets
Fluphenazine HCl Tablets
Fluvastatin Tablets
Levorphanol Tartrate Tablets
Levothyroxine Capsules
Levothyroxine Tablets
Lisdexamfetamine Dimesylate Capsules
Loxapine Capsules
Mesalamine Tablets
Metaxalone Tablets
Methylphenidate HCl Capsules (CD)
Methylphenidate HCl Tablets (BX Rated)
Mexiletine Capsules
Montelukast Sodium Chewable Tablets
Niacin Tablets
Nifedipine Tablets
Olmesartan Tablets
Oseltamivir Phosphate Capsules
Oxybutynin Tablets
Pantoprazole Sodium Tablets
Paroxetine Tablets
Pilocarpine Tablets
Posaconazole Tablets
Primidone Tablets
Probenecid Tablets
Propranolol Capsules
Rabeprazole Sodium Tablets
Terbutaline Tablets
Triamterene HCTZ Capsules
Ursodiol Capsules
Vardenafil HCI Tablets
Verapamil HCl Capsules
Verelan PM Capsules
👍️ 2

Your Recent History

Delayed Upgrade Clock